JP2003521230A - エキソサイトーシス経路タンパク質および使用方法 - Google Patents

エキソサイトーシス経路タンパク質および使用方法

Info

Publication number
JP2003521230A
JP2003521230A JP2000594835A JP2000594835A JP2003521230A JP 2003521230 A JP2003521230 A JP 2003521230A JP 2000594835 A JP2000594835 A JP 2000594835A JP 2000594835 A JP2000594835 A JP 2000594835A JP 2003521230 A JP2003521230 A JP 2003521230A
Authority
JP
Japan
Prior art keywords
seq
protein
exo
nucleic acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000594835A
Other languages
English (en)
Japanese (ja)
Inventor
ルオ・イン
Original Assignee
ライジェル・ファーマシューティカルズ・インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ライジェル・ファーマシューティカルズ・インコーポレイテッド filed Critical ライジェル・ファーマシューティカルズ・インコーポレイテッド
Publication of JP2003521230A publication Critical patent/JP2003521230A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Psychology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
JP2000594835A 1999-01-20 2000-01-20 エキソサイトーシス経路タンパク質および使用方法 Pending JP2003521230A (ja)

Applications Claiming Priority (23)

Application Number Priority Date Filing Date Title
US11653499P 1999-01-20 1999-01-20
US60/116,534 1999-01-20
US11727499P 1999-01-26 1999-01-26
US11731299P 1999-01-26 1999-01-26
US11730999P 1999-01-26 1999-01-26
US11730899P 1999-01-26 1999-01-26
US60/117,312 1999-01-26
US60/117,309 1999-01-26
US60/117,274 1999-01-26
US60/117,308 1999-01-26
US11817799P 1999-02-01 1999-02-01
US11817899P 1999-02-01 1999-02-01
US11817999P 1999-02-01 1999-02-01
US60/118,178 1999-02-01
US60/118,177 1999-02-01
US60/118,179 1999-02-01
US11928699P 1999-02-09 1999-02-09
US60/119,286 1999-02-09
US11999899P 1999-02-11 1999-02-11
US11975999P 1999-02-11 1999-02-11
US60/119,759 1999-02-11
US60/119,998 1999-02-11
PCT/US2000/001431 WO2000043419A2 (fr) 1999-01-20 2000-01-20 Proteine de voies d'exocytose et leurs procedes d'utilisation

Publications (1)

Publication Number Publication Date
JP2003521230A true JP2003521230A (ja) 2003-07-15

Family

ID=27582648

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000594835A Pending JP2003521230A (ja) 1999-01-20 2000-01-20 エキソサイトーシス経路タンパク質および使用方法

Country Status (5)

Country Link
EP (1) EP1161442A2 (fr)
JP (1) JP2003521230A (fr)
AU (1) AU2416600A (fr)
CA (1) CA2359145A1 (fr)
WO (1) WO2000043419A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002952550A0 (en) * 2002-11-08 2002-11-21 The University Of Queensland Modulating TNFalpha Secretion
BR112012028306A2 (pt) 2010-05-06 2020-11-03 Novartis Ag anticorpos para proteína 6 relacionada com lipoproteína de baixa densidade (lrp6) e seus fragmentos, seu uso, ácidos nucléicos, vetores, bem como composições farmacêuticas e combinações
AU2011249782B2 (en) 2010-05-06 2014-10-02 Novartis Ag Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (LRP6) multivalent antibodies
ES2666856T3 (es) 2011-11-04 2018-05-08 Novartis Ag Proteína 6 relacionada con lipoproteínas de baja densidad (LRP6) - constructos extensores de la vida media
CN116790760B (zh) * 2023-08-17 2023-12-12 北京大学人民医院 结肠癌特异性环状rna标记物及其检测引物与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7821398A (en) * 1997-06-06 1998-12-21 Baylor College Of Medicine The mast cell secretory machine as a target for anti-allergy drug development
JP2002507395A (ja) * 1998-02-23 2002-03-12 ライガル ファーマシューティカルズ インコーポレイテッド 開口分泌タンパク質ｅｘｏ１及びｅｘｏ２

Also Published As

Publication number Publication date
EP1161442A2 (fr) 2001-12-12
AU2416600A (en) 2000-08-07
WO2000043419A2 (fr) 2000-07-27
WO2000043419A3 (fr) 2001-02-15
CA2359145A1 (fr) 2000-07-27

Similar Documents

Publication Publication Date Title
JP2002525067A (ja) レプチン誘導遺伝子
JP2003516144A (ja) ヒストン脱アセチル化酵素−８のタンパク質、核酸およびその使用方法
JP2002526099A (ja) Ｎｌｋ１−相互作用タンパク質
JP2001523455A (ja) Ｃｄｋ２タンパク質およびｃｄｋ２タンパク質複合体
US20030040089A1 (en) Protein-protein interactions in adipocyte cells
JP2003521230A (ja) エキソサイトーシス経路タンパク質および使用方法
AU770000B2 (en) Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof
US20080248009A1 (en) Regulation of acheron expression
US7488805B2 (en) Apoptosis proteins
US20060228761A1 (en) Novel RIP3 associated cell cycle proteins, compositions and methods of use
JP2003514548A (ja) 新規ｉａｐ関連細胞周期タンパク質、組成物および使用法
US6387658B1 (en) PCNA-associated cell cycle proteins, compositions and methods of use
AU766809B2 (en) Novel compositions and methods of screening for T-cell and B-cell activation modulators
US7223850B1 (en) Apoptosis proteins
JP2003510049A (ja) Ｔｒａｆ４関連細胞周期タンパク質、組成物および使用法
JP2002507395A (ja) 開口分泌タンパク質ｅｘｏ１及びｅｘｏ２
AU7710500A (en) Pcna associated cell cycle proteins, compositions and methods of use
WO2004087888A2 (fr) Signalisation de neurotransmetteurs permettant la regulation de la duree de vie chez c. elegans
AU7608800A (en) Checkpoint gene associated cell cycle proteins, compositions and methods of use